Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Pediatric Rheumatology
Do you routinely pursue cardiac evaluation in children presenting with post-streptococcal reactive arthritis given the diagnostic overlap with acute rheumatic fever?
Related Questions
Would you consider combination belimumab and anakinra for a patient who has SLE and MAS?
In a patient with SJIA who has been stable on Anakinra however is now planning to conceive or becomes pregnant, would you consider switching to Cimzia?
Do you generally utilize calcium channel blockers on an as needed basis for patients with Raynaud's phenomenon?
When would you consider use of emapalumab for HLH/MAS ?
What are your preferred alternative biologic agents for Blau Syndrome when anti-TNFα therapies are contraindicated?
In a young patient who was vaccinated to chickenpox as a child (no previous varicella infection) should the patient receive a shingles vaccine prior to starting Rinvoq?
How do you treat MAS in patients with systemic JIA or AOSD with HLA-DRB1*15 alleles given risk for DRESS hypersensitivity to IL1 or IL6 inhibitor therapy?
How would you approach a patient with the diagnosis of Yao Syndrome with manifestations including dermatitis, arthralgia, severe keratoconjunctivitis sicca, and gastroparesis who has failed to respond to dupilumab and canakinumab?
How would you approach management of a patient with sJIA that was previously well controlled on tocilizumab but is now having ongoing joint disease activity?
How would you approach a patient with SLE and class II LN who has persistent lupus activity and incomplete B-cell depletion on rituximab therapy?
